Related Experiment Video
Updated: Aug 14, 2026

Murine Kidney Transplant Technique
Published on: October 20, 2015
Cardiovascular disease and the renal transplant recipient
1Department of Nephrology, University of California--Los Angeles Medical Center, Los Angeles, CA 90095, USA. ekendrick@mednet.ucla.edu
Insights
Managing cardiovascular risk factors like hypertension and hyperlipidemia is crucial for renal transplant recipients. Early intervention may improve long-term outcomes and reduce complications in these high-risk patients.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Cardiovascular complications are a major cause of death and illness in kidney transplant recipients.
- Pre-existing conditions like diabetes and hypertension, plus dialysis, often lead to vascular disease before transplantation.
- Vascular disease can worsen or develop post-transplant due to ongoing risk factors.
Purpose of the Study:
- To explore the potential benefits of modifying cardiovascular risk factors in renal transplant patients.
- To highlight the importance of managing hypertension and hyperlipidemia in this population.
Main Methods:
- Review of existing literature on cardiovascular risk factor modification in the general and renal transplant populations.
- Focus on the impact of managing hypertension and hyperlipidemia.
Main Results:
- Cardiovascular risk factor modification is beneficial in the general population.
- Evidence for long-term morbidity and mortality benefits in renal transplant recipients is still limited but promising.
Conclusions:
- Modifying cardiovascular risk factors like hypertension and hyperlipidemia holds significant potential for improving outcomes in renal transplant recipients.
- Further long-term studies are needed to fully establish the impact on morbidity and mortality.
Abstract:
Cardiovascular complications contribute to a significant proportion of the morbidity and mortality in renal transplant patients. Underlying disease states such as diabetes and hypertension as well as risk factors associated with chronic dialysis may cause many patients to have established coronary artery and peripheral vascular disease at the time of transplantation. Progression or new onset of disease can occur after transplantation due to the continued presence of risk factors for cardiovascular disease. The benefit of modification of these risk factors such as hypertension and hyperlipidemia has been well established in the general population and has more recently been explored in the renal transplant population, although long-term studies documenting an improvement in morbidity and mortality are not available. This article focuses on the potential benefit of modification of risk factors in this setting.
Related Concept Videos
Heart Failure Drugs: Diuretics
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations

